SEC Form 4 · accession 0001127602-15-031030
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Kraeutler
Officer — Chairman and CEO · Director
Period of report
Nov 6, 2015
Accepted (ET)
Nov 10, 2015 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 6, 2015 | M | 15,750 | $14.007 | A | 339,511 | D | |
| Common StockF1 | Nov 6, 2015 | D | 15,750 | $19.9451 | D | 323,761 | D | |
| Common StockF2 | Nov 9, 2015 | D | 8,627 | $20.27 | D | 315,134 | D | |
| Common Stock | holding | — | — | — | 703 | I | Held in Meridian Savings & Investment Plan (401K) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F3 | $14.007 | Nov 6, 2015 | M | 15,750 | D | — | Nov 10, 2015 | Common Stock | 15,750 | 0 | D |
Explanation of responses
- F1Prices range from $19.93 per share to $20.03 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- F2information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- F3These options became fully vested in November 2009.